ArticleFrontiers in immunology2025

B and T lymphocyte attenuator (BTLA) and PD-1 pathway dual blockade promotes antitumor immune responses by reversing CD8

Yang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.